Key result
High stromal FAP expression in gastric cancer patients was associated with a shorter median overall survival compared to low expression.
Why the study?
Does stromal fibroblast activation protein alpha promote gastric cancer progression?
Observational (n=60)
No
Does stromal fibroblast activation protein alpha promote gastric cancer progression?
Stromal FAP promotes gastric cancer progression via EMT through the Wnt/β-catenin pathway and is associated with poorer overall survival, highlighting its potential as a prognostic biomarker.
Answers are grounded in this paper and cite their sources.
Does not support FAP testing to guide gastric cancer therapy; hypothesis-generating for stromal-targeted trials.
BACKGROUND: To investigate the influence of fibroblast activation protein alpha (FAP) derived from cancer-associated fibroblasts (CAFs), as well as potential mechanism of epithelial mesenchymal transition (EMT), on gastric cancer (GC) progression. METHODS: Correlation between CAFs-derived FAP and clinical results has been studied by using 60 GC cases. To confirm this relationship, SGC7901 cells were co-cultured with pre-established FAP-overexpressed fibroblasts in vitro and the characteristics including proliferation, migration, invasion and apoptosis abilities were detected subsequently. Meanwhile, SGC and GES1 cells cocultured with FAP-overexpressed fibroblasts were treated with cis-platinum for apoptotic analysis. The underlying EMT was detected by analyzing expression level of E-cadherin, ZO-1, N-cadherin, Vimentin, α-SMA, DKK1 and LEF-1 through western blot and immunofluorescence staining assay. Finally, the tumor-promoting ability of FAP was investigated by utlizing a xenograft gastric cancer nude mouse model. RESULTS: It show that FAP has a high-risk correlation with the malignant level of clinical outcomes in GC patients. FAP promotes the ability of proliferation, migration, invasion, apoptosis-inhibition of SGC7901 cells and induces apoptosis of GES1 cells in vitro. The mechanism study shows that epithelial markers have been down-regulated and mesenchymal markers and Wnt/β-catenin signal pathway related proteins have been up-regulated. Animal assay suggests that tumor burden has been enhanced by FAP significantly in vivo. CONCLUSIONS: Stromal FAP could be a potential prognostic biomarker in GC by promoting cancer progression via EMT through Wnt/ β-catenin signal pathway.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) conducted an observational in Gastric cancer (n=60). High stromal FAP expression vs. Low stromal FAP expression was evaluated on Overall survival (p=<0.01). High stromal FAP expression in gastric cancer patients was associated with a shorter median overall survival compared to low expression.
Synapse has enriched 10 related papers. Consider them for comparative context: